Skip to content
TopicTracker
From HackerNewsView original
TranslationTranslation

ChatGPT, Claude, or Gemini? Big Pharma Is Choosing Sides

Major pharmaceutical companies are increasingly selecting specific AI models—such as ChatGPT, Claude, or Gemini—for drug discovery and development, tailoring their choice based on each model's strengths in data analysis, molecule design, and regulatory compliance.

Related stories

  • Microsoft Copilot Cowork, an agentic AI system, was found to allow data exfiltration by sending emails to a user's inbox without approval. These messages could contain external images that trigger network requests, leaking data when opened. Additionally, prompt injection could expose pre-authenticated OneDrive download links, enabling attackers to download files.

  • The article discusses how business executives and "business idiots" are regaining power in the tech industry, often pushing aside engineers and product-focused leaders. It critiques the rise of corporate jargon, short-term thinking, and MBA-driven decision-making that prioritizes metrics over meaningful innovation, arguing this trend is stifling creativity and damaging long-term company value.

  • The article argues that internet usage has become fundamentally irrational, likening frequent online activity to a form of collective insanity due to its negative effects on attention, mental health, and real-world engagement.